Literature DB >> 24866435

Evaluating the cost-effectiveness of laryngeal examination after elective total thyroidectomy.

Brian Hung-Hin Lang1, Carlos K H Wong, Raymond K Y Tsang, Kai Pun Wong, Birgitta Y H Wong.   

Abstract

BACKGROUND: Although routine laryngeal examination (RLE) after thyroidectomy may cost more than selective laryngeal examination (SLE), it permits earlier detection and treatment of vocal cord palsy (VCP) and so may be cost-saving in the longer term. We compared the 2-year cost-effectiveness between RLE and SLE with RLE performed at 2 weeks (SLE-2w), 1 month (SLE-1m), and 3 months (SLE-3m) after thyroidectomy in the institution's perspective.
METHODS: Our case definition was a hypothetical 50-year-old woman who underwent an elective total thyroidectomy for a benign multinodular goiter. A decision-analytic model was constructed to compare the estimated cost-effectiveness between RLE, SLE-2w, SLE-1m, and SLE-3m after a 2-year period. Outcome probabilities, utilities, and costs were estimated from the literature. The threshold for cost-effectiveness was set at US$50,000/quality-adjusted life-year. Sensitivity and threshold analyses were used to examine model uncertainty.
RESULTS: RLE was not cost-effective because its incremental cost-effectiveness ratio to SLE-2w, SLE-1m, and SLE-3m were US$302,755, US$227,883 and US$247,105, respectively. RLE was only cost-effective when the temporary VCP rate increased >42.7 % or when the cost of RLE equaled zero. Similarly, SLE-2w was only cost-effective to SLE-3m when dysphonia for temporary VCP at 3 months increased >39.13 %, dysphonia for permanent VCP at 3 months increased >50.29 %, or dysphonia without VCP at 3 months increased >42.69 %. However, none of these scenarios appeared clinically likely.
CONCLUSIONS: In the institution's perspective, RLE was not cost-effective against the other three SLE strategies. Regarding to the optimal timing of SLE, SLE-3m appears to be a reasonable and acceptable strategy because of its relative low overall cost.

Entities:  

Mesh:

Year:  2014        PMID: 24866435     DOI: 10.1245/s10434-014-3770-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  3 in total

1.  IPTH cost-effectiveness in thyroid surgery.

Authors:  Davide Inversini; Xiaoli Liu; Hui Sun; Gianlorenzo Dionigi
Journal:  Gland Surg       Date:  2017-08

2.  Association of Hypocalcemia and Magnesium Disorders With Thyroidectomy in Commercially Insured Patients.

Authors:  Rui Han Liu; Christopher R Razavi; Hsien-Yen Chang; Ralph P Tufano; David W Eisele; Christine G Gourin; Jonathon O Russell
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-03-01       Impact factor: 6.223

3.  Mapping complications in thyroid surgery: statistical data are useful for medico-legal management of a recurrent safety issue.

Authors:  Martina Padovano; Matteo Scopetti; Raoul Tomassi; Federico Manetti; Stefano D'Errico; Alessandro Santurro; Giorgio De Toma; Paola Frati; Paolo Miccoli; Vittorio Fineschi
Journal:  Updates Surg       Date:  2022-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.